EN / CN

News

Current Position: Home ››  News

06

2026Year07Month

Meet Newland in Bangkok | CPHI Southeast Asia 2026

Join us at Booth L49 to explore new opportunities in the ASEAN pharmaceutical market and discuss potential partnerships.
[View Details]

23

2026Year06Month

Levamlodipine Besylate API Approved for Marketing!

Newland Pharmaceutical's Levamlodipine Besylate API is now approved for marketing by the NMPA.
[View Details]

21

2026Year06Month

Newland at CPHI China 2026 | APIs, Intermediates & CDMO Solutions

Newland Pharmaceutical connects with global industry partners at CPHI China 2026, highlighting its APIs, intermediates, and CDMO capabilities.
[View Details]

11

2026Year06Month

Newland Pharma Invites You to CPHI China 2026

Meet Newland Pharma at CPHI China 2026 and explore our specialty APIs, pharmaceutical intermediates, and CDMO services.
[View Details]

30

2026Year05Month

Newland Pharmaceutical Welcomes You to FCE Brazil

See you in São Paulo! Newland Pharmaceutical is joining FCE Pharma 2026.
[View Details]
Total56Items   2 / 12Page  Per Page5Items  First Page  Previous  Next  Last Page